← Eichor
Condition: X Linked Severe Combined Immunodeficiency Xscid Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: X Linked Severe Combined Immunodeficiency Xscid

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodefic
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01306019Targeting Real World Usage In Stroke Treatment
Phase N/A · 13 location(s) · Phenox GmbH · NCT07474935Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Phase 1/Phase 2 · 4 location(s) · David Williams · NCT03311503SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03217617Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency
Phase 1 · 1 location(s) · Great Ormond Street Hospital for Children NHS Foundation Tru · NCT03601286Evaluation of Patients With Immune Function Abnormalities
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00128973
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.